Antimicrobial susceptibilities of Streptococcus species that cause septicemia in neutropenic patients
about
New Insight on Epidemiology and Management of Bacterial Bloodstream Infection in Patients with Hematological MalignanciesEmergence of high rates of antimicrobial resistance among viridans group streptococci in the United States.Fluoroquinolone resistance mutations in the parC, parE, and gyrA genes of clinical isolates of viridans group streptococciA randomized trial of roxithromycin in patients with acute leukemia and bone marrow transplant recipients receiving fluoroquinolone prophylaxis.Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center.E test versus agar dilution for antimicrobial susceptibility testing of viridans group streptococci.Molecular relationships and antimicrobial susceptibilities of viridans group streptococci isolated from blood of neutropenic cancer patients.Activities of new fluoroquinolones, ketolides, and other antimicrobials against blood culture isolates of viridans group streptococci from across Canada, 2000.Viridans group streptococci are donors in horizontal transfer of topoisomerase IV genes to Streptococcus pneumoniaeIn vitro activities of eight macrolide antibiotics and RP-59500 (quinupristin-dalfopristin) against viridans group streptococci isolated from blood of neutropenic cancer patients.In vitro activity of cefepime against multidrug-resistant Gram-negative bacilli, viridans group streptococci and Streptococcus pneumoniae from a cross-Canada surveillance study4-week treatment of streptococcal native valve endocarditis with high-dose teicoplaninActivities of potential therapeutic and prophylactic antibiotics against blood culture isolates of viridans group streptococci from neutropenic patients receiving ciprofloxacinChromosomally mediated high-level gentamicin resistance in Streptococcus mitis.Drug efflux and parC mutations are involved in fluoroquinolone resistance in viridans group streptococci.Horizontal transfer of parC and gyrA in fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae.Genetic characterization of fluoroquinolone-resistant Streptococcus pneumoniae strains isolated during ciprofloxacin therapy from a patient with bronchiectasisStrategy for antibiotic therapy in febrile neutropenic patients on selective antibiotic decontamination.Piperacillin/tazobactam/amikacin versus piperacillin/amikacin/teicoplanin in the empirical treatment of neutropenic patients.Ofloxacin versus trimethoprim-sulfamethoxazole for prevention of infection in patients with acute leukemia and granulocytopenia.Teicoplanin in the treatment of gram-positive bacteraemia in neutropenic patients.Prevention of viridans-group streptococcal septicemia in oncohematologic patients: a controlled comparative study on the effect of penicillin G and cotrimoxazole.Screening of aqueous extracts of medicinal herbs for antimicrobial activity against oral bacteria.Prevalence of penicillin-resistant viridans streptococci in healthy children and in patients with malignant haematological disorders.
P2860
Q26799580-92779C33-2929-49D3-B517-923DE4B30CC3Q30452911-D5434A0D-9BBA-4595-A7C1-AB73239AAFE4Q33700561-3343A33A-1D0C-435B-B4FE-9CEA67134171Q33750614-B286833E-AF50-42BC-BC51-FE00338FEE29Q33752287-54DA4B64-15E2-4C16-A98F-84A1A2BB5733Q33957980-A6AF3D99-6194-480B-A80D-F44C90A4658CQ33960926-09889A9B-6F99-46EA-9BAB-6A81CBE0726CQ34107331-12DB6344-2902-4C6A-9DAC-2FEB7A27B130Q35102420-C4836133-3D2E-4F21-BE49-BB65157570BAQ35126797-2E4D204C-4835-48BE-B991-EC1D0BF95975Q35649669-E1441462-3ED6-46AC-B20E-7C6995EB4388Q35845550-34F3E8E5-E68B-468F-B2AE-5A88D90A0231Q35900380-5D3C6B00-2144-49AB-836B-74AB6922AC4AQ35904804-9503D56F-5039-463E-83A2-B1751FC424E8Q39472017-E6E82B9F-8C45-44EE-9900-3DFA032F589FQ39473366-B8EE09A2-50A0-4051-9CB7-856C74D78853Q39743472-E68FC047-EEFF-4D54-B0D4-4F6C8BBDDDECQ40709555-D514107F-E1B7-4C76-9986-E15E2A756E28Q40723790-DA620740-B967-4343-863E-0E1BAC43B84EQ40750976-24F6E971-F576-4019-8F06-37940D947EE5Q40755988-442E846D-19ED-47FC-9075-851671BCA8D6Q44568089-0D38B3AC-75A5-4E43-A1D0-DDC7681666FCQ53724705-42B6E25B-C847-40B6-9D57-DA51024197C8Q54199064-1F497B0A-5A42-43E1-864B-3EEFF4C7FAF5
P2860
Antimicrobial susceptibilities of Streptococcus species that cause septicemia in neutropenic patients
description
1989 nî lūn-bûn
@nan
1989 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Antimicrobial susceptibilities ...... icemia in neutropenic patients
@ast
Antimicrobial susceptibilities ...... icemia in neutropenic patients
@en
type
label
Antimicrobial susceptibilities ...... icemia in neutropenic patients
@ast
Antimicrobial susceptibilities ...... icemia in neutropenic patients
@en
prefLabel
Antimicrobial susceptibilities ...... icemia in neutropenic patients
@ast
Antimicrobial susceptibilities ...... icemia in neutropenic patients
@en
P2093
P2860
P356
P1476
Antimicrobial susceptibilities ...... icemia in neutropenic patients
@en
P2093
Baiocchi P
Brandimarte C
Girmenia C
Venditti M
P2860
P304
P356
10.1128/AAC.33.4.580
P407
P577
1989-04-01T00:00:00Z